PXMP2 inhibits tumor stemness and immune infiltration in hepatocellular carcinoma based on stemness risk.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02976-4
- By:
- Publication type:
- Article
Works by Qu, Jiamu
Results: 4
1
2
Prognostic and predictive role of a metabolic rate‐limiting enzyme signature in hepatocellular carcinoma.
- Published in:
- Cell Proliferation, 2021, v. 54, n. 10, p. 1, doi. 10.1111/cpr.13117
- By:
- Publication type:
- Article
3
A pan-cancer analysis of the prognostic and immunological roles of matrix metalloprotease-1 (MMP1) in human tumors.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 01, doi. 10.3389/fonc.2022.1089550
- By:
- Publication type:
- Article
4
A New Clinical Nomogram From the TCGA Database to Predict the Prognosis of Hepatocellular Carcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 12, p. 1, doi. 10.3389/fonc.2021.698980
- By:
- Publication type:
- Article